Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the European Union
27 juin 2023 07h00 HE
|
Amicus Therapeutics, Inc.
PHILADELPHIA, June 27, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for...